Safe Orthopaedics SA (SAFOR)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Safe Orthopaedics SA (SAFOR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011414
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Safe Orthopaedics SA (Safe Orthopaedics) is medical equipment company that manufactures and markets minimally invasive devices for spinal surgery. The company’s product portfolio includes implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, percutaneous auto-correction screws and leaner positioning cages. Safe Orthopaedics also provides pedicle screws and lumber cage instrument kits. Its instruments are used for the treatment of trauma and degenerative pathologies. The company markets its products through a network of distributors across Europe, South America, Africa and Australia. Safe Orthopaedics is headquartered in Paris, France.

Safe Orthopaedics SA (SAFOR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Safe Orthopaedics SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Safe Orthopaedics SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Safe Orthopaedics SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Safe Orthopaedics SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Safe Orthopaedics SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Safe Orthopaedics SA, Medical Equipment, Deal Details 11
Private Equity 11
Safe Orthopaedics Raises USD3.5 Million in Private Equity Financing 11
Equity Offering 12
Safe Orthopaedics Raises USD11 Million in IPO 12
Debt Offering 13
Safe Orthopaedics Raises USD0.7 Million in Private Placement of Notes 13
Safe Orthopaedics Raises Additional USD0.6 Million in Private Placement of Notes Due 2024 14
Safe Orthopaedics Raises USD0.6 Million in Second Tranche of Private Placement of Notes Due 2017 15
Safe Orthopaedics Raises USD0.6 Million in First Tranche of Private Placement of Notes Due 2017 16
Safe Orthopaedics SA – Key Competitors 17
Safe Orthopaedics SA – Key Employees 18
Safe Orthopaedics SA – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Strategy And Business Planning 20
Feb 15, 2017: Safe Orthopaedics Offers New Technologies to Treat Traumatic Injuries Due to Osteoporosis or Bone Metastases 20
Jun 27, 2016: Safe Orthopaedics expands into Latin America 21
Financial Announcements 22
Oct 09, 2017: Safe Orthopaedics: Very Strong Revenue Growth in Q3 2017: +63% 22
Jul 10, 2017: Safe Orthopaedics: Strong Growth Momentum in Q2 2017: +37% 23
May 09, 2017: Safe Orthopaedics: Strong acceleration in growth during Q1 2017 24
Apr 28, 2017: Safe Orthopaedics Reports Its Full-Year Results for 2016 25
Jan 19, 2017: Safe Orthopaedics Reports Revenue Growth of 10% in FY 2016, with an Acceleration in the Fourth Quarter 27
Oct 13, 2016: Safe Orthopaedics reports its revenue for the first 9 months of 2016 and its cash position 28
Sep 27, 2016: Safe Orthopaedics: Half-Year 2016 Results 29
Jul 12, 2016: Safe Orthopaedics announces adjusted second – quarter 2016 revenue: +29% 30
Apr 28, 2016: Safe Orthopaedics: Full-year 2015 results and first-quarter 2016 revenue 31
Feb 11, 2016: Safe Orthopedics Announces 2015 revenue: +23% to €2.5 million 33
Corporate Communications 34
Nov 09, 2017: François-Henri Reynaud Appointed as Safe Orthopaedics’ Chief Financial Officer 34
Sep 14, 2017: Safe Orthopaedics Announces the Forthcoming Arrival of Its New Chief Financial Officer and the Strengthening of Its Sales Team 35
Apr 24, 2017: Pascale Davis, an internationally renowned expert on the spine market, joins Safe Orthopaedics as Global Head of Marketing 36
Mar 06, 2017: Safe Orthopaedics Expands into Germany and Appoints Jochen Esser as Head of Sales Germany 37
Dec 21, 2016: Safe Orthopaedics Appoints Its Scientific Advisory Board Consisting of Key Opinion Leaders in the Field of Back Surgery 38
Jun 30, 2016: Pierre Dumouchel’s interim appointment as Chief Executive Officer made permanent 39
Mar 02, 2016: Safe Orthopaedics: Appointment of Pierre Dumouchel, co-founder of Safe Orthopaedics, as Interim Chief Executive Officer 40
Legal and Regulatory 41
Apr 10, 2017: Safe Orthopaedics Products Listed by AP-HP Paris Hospitals 41
Product News 42
Oct 20, 2016: A Randomized Study Confirms the Benefits of Safe Orthopaedics’ Products in a Leading French Teaching Hospital 42
Other Significant Developments 43
Apr 13, 2016: Safe Orthopaedics expands its business to the Asia-Pacific region by entering into a distribution agreement covering Australia and New Zealand 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Safe Orthopaedics SA, Medical Equipment, Key Facts, 2016 2
Safe Orthopaedics SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Safe Orthopaedics SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Safe Orthopaedics SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Safe Orthopaedics SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Safe Orthopaedics SA, Deals By Market, 2011 to YTD 2017 9
Safe Orthopaedics SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Safe Orthopaedics Raises USD3.5 Million in Private Equity Financing 11
Safe Orthopaedics Raises USD11 Million in IPO 12
Safe Orthopaedics Raises USD0.7 Million in Private Placement of Notes 13
Safe Orthopaedics Raises Additional USD0.6 Million in Private Placement of Notes Due 2024 14
Safe Orthopaedics Raises USD0.6 Million in Second Tranche of Private Placement of Notes Due 2017 15
Safe Orthopaedics Raises USD0.6 Million in First Tranche of Private Placement of Notes Due 2017 16
Safe Orthopaedics SA, Key Competitors 17
Safe Orthopaedics SA, Key Employees 18

★海外企業調査レポート[Safe Orthopaedics SA (SAFOR)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kiadis Pharma NV (KDS):製薬・医療:M&Aディール及び事業提携情報
    Summary Kiadis Pharma NV (Kiadis) is a biopharmaceutical company that develops and markets cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company offers cellular products including ATIR101 and ATIR201 for infusion. Its ATIR101 lowers the risks …
  • Daiichi Sankyo Co Ltd (4568):医療機器:M&Aディール及び事業提携情報
    Summary Daiichi Sankyo Company Ltd (Daiichi Sankyo) is a holding company that carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs, vaccines, and others. Its portfolio encompa …
  • Spectra Energy Partners, LP (SEP)-石油・ガス分野:企業M&A・提携分析
    Summary Spectra Energy Partners, LP (Spectra Energy), a subsidiary of Enbridge Inc., is master limited partnership operating in mid-stream energy. The company conducts transmission, storage and gathering of natural gas. It also carries out the transportation and storage of crude oil, and the transpo …
  • National OilWell Varco, Inc.:企業の戦略・SWOT・財務情報
    National OilWell Varco, Inc. - Strategy, SWOT and Corporate Finance Report Summary National OilWell Varco, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PetroChina Co Ltd (857):企業の財務・戦略的SWOT分析
    PetroChina Co Ltd (857) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Blue Cross (Asia-Pacific) Insurance Limited:企業の戦略・SWOT・財務情報
    Blue Cross (Asia-Pacific) Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary Blue Cross (Asia-Pacific) Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Tosoh Corp (4042):企業の財務・戦略的SWOT分析
    Tosoh Corp (4042) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ISU ABXIS Co Ltd (086890):製薬・医療:M&Aディール及び事業提携情報
    Summary ISU ABXIS Co Ltd (ISU ABXIS), a subsidiary of ISU Chemical Co Ltd is a biotechnology company that discovers and develops diagnostic products and therapeutic antibodies. The company’s products include fabagal, abcertin, and clotinab. It offers clinical labs, in vitro diagnostics, chemotherapy …
  • Heron Therapeutics Inc (HRTX)-製薬・医療分野:企業M&A・提携分析
    Summary Heron Therapeutics Inc (Heron), formerly A.P. Pharma, Inc., is a biotechnology company that uses its proprietary polymer-based drug delivery platform to develop novel, patient-focused therapeutic products for patients suffering from cancer and pain. Its proprietary Biochronomer technology is …
  • Alleghany Corporation:戦略・SWOT・企業財務分析
    Alleghany Corporation - Strategy, SWOT and Corporate Finance Report Summary Alleghany Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pint Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Pint Pharma GmbH (Pint Pharma), a subsidiary of Pint Pharma International SA, is a developer, manufacturer and marketer of originator drugs in rare disease, oncology and specialty conditions. The company offers its products in the form of tablets, injections, small compounds, drugs, implants …
  • Tommy Hilfiger Licensing LLC:企業の戦略・SWOT・財務情報
    Tommy Hilfiger Licensing LLC - Strategy, SWOT and Corporate Finance Report Summary Tommy Hilfiger Licensing LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • Bosch Sensortec GmbH:企業の戦略的SWOT分析
    Bosch Sensortec GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Omnova Solutions Inc (OMN):企業の財務・戦略的SWOT分析
    Omnova Solutions Inc (OMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Badger Meter Inc (BMI):企業の財務・戦略的SWOT分析
    Badger Meter Inc (BMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • NSD Co Ltd (9759):企業の財務・戦略的SWOT分析
    NSD Co Ltd (9759) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Can-One Berhad:企業の戦略・SWOT・財務情報
    Can-One Berhad - Strategy, SWOT and Corporate Finance Report Summary Can-One Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sociedad General de Aguas de Barcelona SA:企業の戦略的SWOT分析
    Sociedad General de Aguas de Barcelona SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Richter Gedeon Nyrt (RICHTER)-医療機器分野:企業M&A・提携分析
    Summary Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆